Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries-Reference-Cited by-同舟云学术

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries

Published:2015-10-30 Issue:2 Volume:71 Page:367-371
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Neogi Ujjwal,Häggblom Amanda,Singh Kamalendra,Rogers Leonard C.,Rao Shwetha D.,Amogne Wondwossen,Schülter Eugen,Zazzi Maurizio,Arnold Eddy,Sarafianos Stefan G.,Sönnerborg Anders

Funder

Karolinska Institutet Research Foundation

Swedish International Developing Agency

Swedish Civil Contingencies Agency

Swedish Research Council

Mizzou Advantage

NIH

molecular modelling

Mizzou Advantage funds

NIAID

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/2/367/17429882/dkv359.pdf

Reference20 articles.

1. Global trends in molecular epidemiology of HIV-1 during 2000–2007

2. Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100 000 copies/ml or less

3. Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors

4. Extended high viremics

5. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. A fast-screening dispersive liquid–liquid microextraction–gas chromatography–mass spectrometry method applied to the determination of efavirenz in human plasma samples;Analytical and Bioanalytical Chemistry;2021-09-23

3. HIV-1 infection among women in Israel, 2010–2018;BMC Infectious Diseases;2020-09-07

4. Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV;Southern African Journal of HIV Medicine;2019-07-23

5. A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort;BMC Infectious Diseases;2019-07-01